Clinical trial
Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects
NCT00498745 · Puma Biotechnology, Inc., Industry · Completed
Key facts
| NCT number | NCT00498745 |
|---|---|
| Title | Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects |
| Official title | A Single Dose Bioavailability Study of 2 New Formulations of HKI-272 (240 mg) Compared With a Reference Capsule and an Oral Solution in Healthy Adult Subjects |
| Lead sponsor | Puma Biotechnology, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | neratinib |
| Enrollment | 36 |
| Start date | Jul 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 10, 2007 |
| Last update posted | May 14, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: